Increasing Prevelance of Leishmaniasis to propel growth of the Leishmaniasis Treatment Market

 
Leishmaniasis Treatment Market

Market Overview:

Leishmaniasis is a vector-borne parasitic disease caused by protozoan parasites of the genus Leishmania. It is transmitted by the bite of infected female phlebotomine sand flies. The disease causes a wide variety of clinical symptoms, the most common being cutaneous and visceral leishmaniasis. There are several treatment options available for leishmaniasis including pentavalent antimonials, miltefosine, paromomycin, and amphotericin B. While these drugs are used as first line therapies, resistance has increased considerably. Hence, there is significant need for safe and effective treatment options against leishmaniasis.

Market key trends:
One of the key trends in the Leishmaniasis Treatment Market Demand is growing preference for combination therapies over monotherapies. Combination therapies involve use of two or more antileishmanial drugs simultaneously that helps in decreasing treatment duration and prevents development of drug resistance. For instance, combination of sodium stibogluconate and paromomycin is recommended as first line treatment for visceral leishmaniasis. Moreover, several pipeline drugs are combination therapies as they provide higher cure rates compared to conventional monotherapy regimens. Furthermore, rising investment by pharmaceutical companies in R&D of novel drug candidates is also contributing to market growth. For example, new oral drug candidates such as AN3807, DL1900 and OZP091 are being developed to offer safer and more effective treatment options for leishmaniasis patients.
Porter’s Analysis

Threat of new entrants: The threat of new entrants is moderate due to high capital requirements for R&D and manufacturing in pharmaceutical industry. Bargaining power of buyers: The bargaining power of buyers is low as standard treatment options are limited and buyers have less influence over prices.

Bargaining power of suppliers: Suppliers have moderate power due to availability of alternative suppliers and less differentiation in raw materials.

Threat of new substitutes: Threat of new substitutes is low as alternative treatment options are very limited for leishmaniasis disease currently.

Competitive rivalry: Competition is high among existing players to gain higher market share.

Key Takeaways

The global leishmaniasis treatment market size is expected to reach US$ 69.4  Million by 2030, exhibiting a CAGR of 4.4% over the forecast period. Increasing prevalence of leishmaniasis disease globally is majorly driving the market.

Regional analysis: North America region currently dominates the leishmaniasis treatment market and is expected to continue its dominance owing to growing research activities for leishmaniasis treatment. However, Asia Pacific region is anticipated to witness fastest growth during the forecast period attributed to rising cases of leishmaniasis disease in developing countries such as India and China.

Key players: Key players operating in the leishmaniasis treatment market are Knight Therapeutics, gland pharma, Sanofi, Novartis, GloxoSmithKline, Pfizer, Cheplapharm Arzneimittel GmbH and Jassen Pharmaceutical. These players are focusing on development and commercialization of advanced treatment options to gain competitive edge in the market.

Read More

https://www.dailyprbulletin.com/artificial-intelligence-is-fastest-growing-segment-fueling-the-growth/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more